Real-World Single-Center Experience with Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C Genotype 1 Patients

BACKGROUND/AIMS: The approval of sofosbuvir (SOF), a direct-acting antiviral, has revolutionized the treatment of chronic hepatitis C virus (HCV). METHODS: We assessed the sustained virological response (SVR) of SOF-based regimens in a real-world single-center setting for the treatment of chronic HC...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Gut Liver
Glavni autori: Shin, Hyun Phil, Burman, Blaire, Kozarek, Richard A., Zeigler, Amy, Wang, Chia, Lee, Houghton, Zehr, Troy, Edwards, Alicia M., Siddique, Asma
Format: Artigo
Jezik:Inglês
Izdano: Editorial Office of Gut and Liver 2017
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5593334/
https://ncbi.nlm.nih.gov/pubmed/28651301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl16447
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items